Back to Search
Start Over
Carfilzomib, dexamethasone and daratumumab in relapsed or refractory multiple myeloma: results of the phase III study CANDOR by prior lines of therapy
- Authors :
- Quach, H
Nooka, A
Samoylova, O
Venner, CP
Kim, K
Facon, T
Spencer, A
Usmani, SZ
Grosicki, S
Suzuki, K
Delimpasi, S
Weisel, K
Obreja, M
Zahlten-Kumeli, A
Mateos, M-V
Quach, H
Nooka, A
Samoylova, O
Venner, CP
Kim, K
Facon, T
Spencer, A
Usmani, SZ
Grosicki, S
Suzuki, K
Delimpasi, S
Weisel, K
Obreja, M
Zahlten-Kumeli, A
Mateos, M-V
- Publication Year :
- 2021
Details
- Database :
- OAIster
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1315690149
- Document Type :
- Electronic Resource